Skip to content

Study of the effectiveness of hemoderivates

Study of the effectiveness of blood products in alveolar repair

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10vc6r63
Enrollment
Unknown
Registered
2023-01-14
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exodontia

Interventions

This study will be split-mouth, each alveolus will be considered an individual experimental unit and will be randomly divided by drawing with brown envelope in 2 groups (Experimental and control) befo

Sponsors

Éwerton Daniel Rocha Rodrigues
Lead Sponsor
Universidade de Pernambuco
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 50 years; no systemic disease; not use medications that interfere with the procedure on the day or week prior to the research; present a surgical site with no current signs and symptoms of infection; present mandibular third molars in similar positions and with indication for extraction

Exclusion criteria

Exclusion criteria: History of pregnancy or lactation; with a history of allergy to any drug used in the experiment and not participating in all phases of the proposed research

Design outcomes

Primary

MeasureTime frame
It is expected to elucidate whether there is a difference in the repair of alveoli filled with advanced platelet-rich fibrin and platelet- and leukocyte-rich fibrin.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactÉwerton Rocha Rodrigues

Faculdade de Odontologia da Universidade de Pernambuco

ewertondaniel27@hotmail.com+55 (81) 31847659

Outcome results

None listed

Source: REBEC (via WHO ICTRP)